MacroGenics specializes in the discovery and development of next‑generation antibody‑based therapeutics, with a robust pipeline focused on oncology, autoimmune disorders, and infectious diseases. The company leverages cutting‑edge technologies such as bi‑specific antibodies, Fc optimization, and monoclonal antibody platforms to create innovative medicines that address unmet medical needs. MacroGenics has forged strategic partnerships with leading pharmaceutical and biotechnology firms worldwide, amplifying its research impact and accelerating product development. With a dedicated team of over 300 professionals, the company fosters a culture of innovation, open communication, and teamwork, positioning employees as its most valuable asset.
The Senior Scientist II - Translational Pathologist will support tissue-based pathology activities across MacroGenics’ antibody-drug conjugate (ADC) and immunotherapy programs.
MacroGenics specializes in the discovery and development of next‑generation antibody‑based therapeutics, with a robust pipeline focused on oncology, autoimmune disorders, and infectious diseases. The company leverages cutting‑edge technologies such as bi‑specific antibodies, Fc optimization, and monoclonal antibody platforms to create innovative medicines that address unmet medical needs. MacroGenics has forged strategic partnerships with leading pharmaceutical and biotechnology firms worldwide, amplifying its research impact and accelerating product development. With a dedicated team of over 300 professionals, the company fosters a culture of innovation, open communication, and teamwork, positioning employees as its most valuable asset.
Revolution Medicines